SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 101.30-2.5%Nov 19 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: George Sepetjian who wrote (662)6/17/1998 1:12:00 PM
From: Rocketman  Read Replies (2) of 3202
 
Yeah, I agree, INCY just doesn't seem to qualify for the R&D hype premium anymore, the revenues and profits are only more than doubling every year. Of course, companies with no revenue or profits are easier to imagine having 10X increases every year. And companies like ENMD are obviously worth more - NOT! Put some more stuff on the VD thread last night on INCY and PKN - check it out.

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News